PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
Trial details
- Registry ID
- NCT06602271
- Drugs studied
- PF614 capsule
TrialRedline tracks 2 clinical trials sponsored by Ensysce Biosciences: 1 Phase 3, 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)NCT06602271 | PF614 capsule | Recruiting | 2026-08Estimated |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)NCT06629402 | PF614 | Completed | 2023-11-14Actual |
Names as written in the registry records.
NCT06602271 · Ensysce Biosciences
Before: 300 participants (planned). After: 320 participants (planned).
Before: Mar 2026. After: Aug 2026.
Before: Not yet recruiting. After: Recruiting.